TuesdayMay 04, 2021 2:28 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Inks Distribution Agreement for Rapid COVID-19 Test Kits; Expands Commercial Leadership Team in Anticipation of Strong, Sustainable Sales 

XPhyto Therapeutics Corp. recently announced it has entered into a distribution, storage and logistics agreement with a German distributor with an established network throughout Germany Germany holds promise due to regulations requiring mandatory weekly testing for its citizens; this has the possibility of ramping up sales Anticipating the increase in sales and distribution, XPhyto expanded its commercial leadership team by bringing on board Mr. Wolfgang Probst and Mr. Manfred Buchberger Mr. Probst will be the company’s Chief Operations Officer (“COO”), while Mr. Buchberger will be the Head of Corporate Development at wholly owned subsidiary XP Diagnostics GmbH The approvals XPhyto…

Continue Reading

TuesdayMay 04, 2021 2:04 pm

QualityStocksNewsBreaks – Splash Beverage Group Inc.’s (SBEV) Copa Di Vino Featured in Yahoo! Life Article

Splash Beverage Group (OTCQB: SBEV), a holding company of a leading portfolio of beverage brands, was featured in a recent article on Yahoo! Life titled, “Enjoy the Moment Wherever Summer Takes You with Copa Di Vino.” One of SBEV’s portfolio brands, Copa Di Vino is the leading producer of premium “wine by the glass” in the U.S. Produced in the Columbia Valley, Copa Di Vino is readily available on the go without the requirement of a bottle, corkscrew or glass. Open, drink and enjoy. “If you’re as excited about summer as we are, then chances are you already have some…

Continue Reading

TuesdayMay 04, 2021 1:25 pm

Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Inks LOI to Acquire Oregon Retail Chain Store

Retail chain store projected to generate estimated $10M annually Company CEO calls acquisition “transformative” Retail is valued resource for GLH development of product lines, execution on brand messaging Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF), a proven, consumer-driven cannabis company in both the medicinal and recreational marijuana market segments, has signed a letter of intent (“LOI”) to acquire a retail chain in Northwest Oregon, which is forecast to generate an estimated $10 million in annual run rate revenue (https://ibn.fm/dRY8o).  “The acquisition of this retail chain will be transformative for GLH, as it would further cement us as a leader in…

Continue Reading

TuesdayMay 04, 2021 12:59 pm

Splash Beverage Group Inc. (SBEV) Defines Craft with Unique SALT Tequila Offering  

Definition of craft spirits differs widely from distillery to consumer SBEV’s SALT Tequila strives to stand out among tequila crowd SALT Naturally Flavored Tequila is 100% Blue Agave, 80 proof Careful attention to detail results in mellow, sweet, fully developed agave flavor unmatched in industry The definition of craft distillery varies throughout the industry; in fact, the American Craft Spirits Association (“ACSA”) has decided not to define craft but allow its members and consumers to ultimately determine their own definition (https://ibn.fm/iKQzn). Splash Beverage Group (OTCQB: SBEV), a holding company of leading portfolio of beverage brands, has defined the term with…

Continue Reading

TuesdayMay 04, 2021 12:58 pm

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Unveils Barrier-Free Line of Hemp-Derived CBD Products

Grapefruit USA (OTCQB: GPFT), a fully licensed premier manufacturer and distributor in the legal cannabis marketplace, recently launched a new U.S. e-commerce website to serve as the online home for its growing portfolio of Hourglass(TM) CBD product lines. “Grapefruit is gratified and proud to offer our U.S. and international customers a convenient, one-stop shop to purchase our hemp CBD-only-derived versions of Hourglass time-release delivery cream powered products,” said Grapefruit CEO Bradley J. Yourist. He noted that the company’s original Hourglass technology-based products contained THC and, therefore, could not be sold across state lines or internationally. “No such federal legal barrier…

Continue Reading

TuesdayMay 04, 2021 12:45 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Set for ‘Strong Foray’ into Insurtech, Predictive Services

FingerMotion (OTCQX: FNGR) operates primarily in China to deliver mobile tech-related services with an aim to acquire more than a billion customers for its mobile payment, mobile phone recharge platform and insurtech services through a step-by-step developmental strategy. “FingerMotion’s service offerings include telecommunication products and services and SMS and MMS services, the company’s core revenue sources, as well as the rich communication services and big-data insights launching this year,” reads a recent article discussing the company’s positioning. “The big data product has the potential to provide the foundation for the company’s ‘strong foray’ into insurtech offerings as well as predictive…

Continue Reading

TuesdayMay 04, 2021 12:43 pm

FingerMotion Inc. (FNGR) Leveraging Raw Mobile Data to Offer Big Data Insights

FingerMotion has forged strong relationships with the three largest telecommunication companies in China The relationships have given FNGR access to subscriber data, allowing it to test its proprietary data analytics algorithms in real-time The algorithms, created by FingerMotion’s Big Data Insights Division, leverage raw mobile data to create a user persona A technological company, FingerMotion (OTCQX: FNGR) has evolved over the years. What began as a mobile gaming company, launched in 2016, morphed into a mobile payment and recharge service provider in 2018, offering these services to China Unicom’s (NYSE: CHU) customers. That same year, FNGR was awarded a contract…

Continue Reading

TuesdayMay 04, 2021 12:33 pm

QualityStocksNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Holds Unique View Across EV Value Chain

Ideanomics (NASDAQ: IDEX) is a global company facilitating the adoption of commercial electric vehicles and supporting next-generation financial services and fintech products. The global company is driving next generation solutions to energy consumption and, through its Ideanomics Mobility division, has evolved into a synergistic ecosystem of subsidiaries and investments in the electric vehicle (“EV”) industry. A recent article regarding this quotes Ideanomics CEO Alf Poor, stating “We have a unique view across what we believe is the EV value chain because we have operations in China, South Asia, in Malaysia, in Europe and in North America, and we have interesting…

Continue Reading

TuesdayMay 04, 2021 12:25 pm

QualityStocksNewsBreaks – First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) Releases Additional Assay Results from Augustus Lithium Property

First Energy Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, has announced additional assay results from the channel sampling program conducted at its Augustus Lithium Property in Quebec. The samples taken from the Beluga Pegmatite of the Canadian Lithium Prospect cut a 31-meter-wide section with an average of 0.37% lithium oxide (Li2O), which includes four meters of spodumene pegmatite at 1.20$ Li2O. The company has been doing continuous ground exploration work since February with the objective of locating and confirming historical lithium pegmatite occurrences on two of its locations: Augustus and Canadian Lithium Prospects. The work, which includes field exploration…

Continue Reading

TuesdayMay 04, 2021 12:18 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Commences Site Recruitment for Acclaim-2 Clinical Trial

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced it has commenced clinical trial site recruitment for its upcoming Acclaim-2 clinical trial for the treatment of non-small cell lung cancer (“NSCLC”). An open-label, multicenter Phase 1/2 clinical trial, Acclaim-2 combines Genprex’s lead drug candidate, REQORSA(TM) immunogene therapy, with Merck & Co Inc.’s Keytruda in patients with late-stage NSCLC who are low expressors (1% to 49%) of the protein programmed death-ligand 1 ("PD-L1"). “Our clinical team remains focused on engaging with leading clinical investigators and esteemed research institutions in…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered